CEL-SCI Corporation today announced that in a recent meeting the U.S. Food and Drug Administration (FDA) concurred with the Company's approach to patient selection using low PD-L1 tumor expression in ...

LakeShore Biopharma Co., Ltd (Nasdaq: LSB) (“LakeShore Biopharma” or the “Company”), a global leader in the discovery, development, manufacturing, and delivery of next-generation vaccines and ...

Research and development expense was $15.5 million for the third quarter of 2024, as compared to $7.6 million for the prior ...

It comes after England's health watchdog launched a probe into a celebrity-backed prviate menopause clinic over allegations it was prescribing patients high levels of HRT.

Net revenue of $70.8 million in Q3 2024 driven by 30% increase in UDENYCA® net revenue, quarter-over-quarter – ...

Cencora, Inc. (NYSE: COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America ("RCA"), a leading management services organization (MSO) of retina ...

Ziftomenib combined with 7+3 in 1L NPM1-m or KMT2A-r adverse risk AML patients selected for oral presentation on Saturday, December 7th –– ...

Electronics and Telecommunications Research Institute (ETRI) stated that they have successfully developed a new technology ...

Investment in artificial intelligence (AI) is rising fast. The International Data Corporation projects global spending on AI R&D will reach ...

One Latino civil rights organization has released a new set of guidelines to inform people of their federally protected rights while getting medical care.

York County Commissioner Julie Wheeler provided an update on the investigation into flagged voter registration forms. She ...